A Multi-center, Open, One-arm Study to Investigate the Safety and Efficacy of Daily Oral Administration of T00660AA for the Treatment of Endometriosis Over 52 Weeks (Follow-up to Study 307041) [EXTENSION OF 700008124]

Trial Profile

A Multi-center, Open, One-arm Study to Investigate the Safety and Efficacy of Daily Oral Administration of T00660AA for the Treatment of Endometriosis Over 52 Weeks (Follow-up to Study 307041) [EXTENSION OF 700008124]

Completed
Phase of Trial: Phase III

Latest Information Update: 30 Jan 2014

At a glance

  • Drugs Dienogest (Primary)
  • Indications Endometriosis
  • Focus Adverse reactions; Registrational
  • Sponsors Bayer
  • Most Recent Events

    • 17 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top